What is the treatment for proctitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Proctitis

The initial treatment for proctitis should be ceftriaxone 250 mg IM in a single dose PLUS doxycycline 100 mg orally twice a day for 7 days while awaiting diagnostic test results. 1

Diagnosis and Etiology

Proctitis refers to inflammation of the rectum and can be caused by:

  • Sexually transmitted infections (most common in those with receptive anal intercourse):

    • Neisseria gonorrhoeae
    • Chlamydia trachomatis (including LGV serovars)
    • Treponema pallidum (syphilis)
    • Herpes simplex virus (HSV) 2, 1
  • Non-infectious causes:

    • Inflammatory bowel disease (ulcerative proctitis)
    • Radiation
    • Ischemia
    • Medication-induced 3

Diagnostic Approach

All patients with suspected proctitis should undergo:

  1. Anoscopic examination
  2. Gram-stained smear of anorectal exudate to check for polymorphonuclear leukocytes
  3. Testing for:
    • HSV (PCR or culture)
    • N. gonorrhoeae (NAAT or culture)
    • C. trachomatis (NAAT)
    • T. pallidum (darkfield if available and serologic testing)
    • HIV and syphilis testing 2, 1

Treatment Algorithm

1. Infectious Proctitis (Sexually Transmitted)

  • Initial empiric therapy (while awaiting test results):

    • Ceftriaxone 250 mg IM in a single dose PLUS
    • Doxycycline 100 mg orally twice a day for 7 days 2, 1
  • Special considerations:

    • If bloody discharge, perianal ulcers, or mucosal ulcers are present with positive rectal chlamydia NAAT or HIV infection: extend doxycycline to 3 weeks total (for presumptive LGV) 2, 1
    • If painful perianal ulcers are present: add treatment for genital herpes (acyclovir, valacyclovir, or famciclovir) 1

2. Ulcerative Proctitis (Inflammatory)

  • First-line treatment:

    • Mesalamine (5-ASA) suppository 1 g once daily 1, 4
  • For inadequate response:

    • Combine topical mesalamine with oral mesalamine or topical steroids 1
    • Suppositories are preferred over enemas for proctitis as they deliver medication more effectively to the rectum 1

Follow-up and Partner Management

  • Patients should abstain from sexual intercourse until they and their partner(s) have completed treatment and symptoms have resolved 2, 1
  • For proctitis associated with gonorrhea or chlamydia, perform retesting 3 months after treatment 2
  • Sexual partners from the past 60 days should be evaluated, tested, and treated presumptively 1

Common Pitfalls to Avoid

  1. Missing co-infections: Multiple pathogens may be present simultaneously; comprehensive testing is essential 1, 5

  2. Misdiagnosis: Distinguishing between infectious proctitis and inflammatory bowel disease can be challenging due to overlapping symptoms and endoscopic findings 6, 5

  3. Undertreatment: Herpes proctitis can be especially severe in patients with HIV infection and may require more aggressive therapy 2, 1

  4. Poor adherence: Low adherence to rectal mesalamine therapy can hinder remission in patients with ulcerative proctitis 4

  5. Overlooking proximal constipation: This can affect drug delivery in distal colitis and should be addressed with laxatives if present 1

  6. Inadequate follow-up: Reinfection may be difficult to distinguish from treatment failure, making proper follow-up essential 1

References

Guideline

Proctitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and treatment of ulcerative proctitis.

Journal of clinical gastroenterology, 2004

Research

Infectious proctitis: a necessary differential diagnosis in ulcerative colitis.

International journal of colorectal disease, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.